Heart device under review: essential pro study aims to confirm safety

NCT ID NCT06631157

Recruiting now Disease control Sponsor: Fundación EPIC Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 100 people with coronary artery disease who have already been treated with the Essential Pro device. Researchers want to confirm the device is safe and works as intended, meeting new European safety rules. The main goal is to see if the device prevents serious heart problems like heart attack or the need for repeat procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Essential Pro (a balloon catheter device used to open blocked heart arteries)
What this could lead to: If successful, this study confirms the device is safe and works well for treating blocked arteries, supporting its continued use in routine care.
What could go wrong: This is a small, single-center, non-randomized study with no comparison group. It only observes outcomes in people already treated, so results may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder myocardial ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE ISCHEMIC HEART DISEASE

Contacts and locations

Locations

Princess Margaret Hospital
RECRUITING

Lai Chi Kok, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.